Claudio Viscoli

36.6k citations

301 papers · 14.6k indexed · 5 hit papers · h-index 60

Impact in

Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 23
Molecular Medicine 43
- Antibiotic Resistance in Bacteria 43

Co-authors: Matteo Bassetti Małgorzata Mikulska Elio Castagnola Valerio Del Bono Thierry Calandra Daniele Roberto Giacobbe M. P. Glauser Mario Tumbarello
Journals: Clinical Infectious Diseases (18 papers)Clinical Microbiology and Infection (14 papers)Journal of Chemotherapy (12 papers)Journal of Antimicrobial Chemotherapy (11 papers)BMC Infectious Diseases (9 papers)
Partner nations: Italy United States Switzerland

In The Last Decade

Claudio Viscoli

298 papers receiving 14.2k citations

Hit Papers

5 papers align trajectories log scale

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) 2019 · 637 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2016 Haematologica
2015 Journal of Antimicrobial Chemotherapy
2013 Haematologica
2012 Clinical Infectious Diseases

Peers

Countries citing papers authored by Claudio Viscoli

Since Specialization

Citations

This map shows the geographic impact of Claudio Viscoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Viscoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Viscoli more than expected).

Fields of papers citing papers by Claudio Viscoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Viscoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Viscoli. The network helps show where Claudio Viscoli may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Claudio Viscoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claudio Viscoli Line = papers co-authored together Claudio Viscoli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers Journal of Clinical Microbiology ·Marjorie Cornu, Boualem Sendid, M. Virmond, Nadine François, Małgorzata Mikulska, Valérie Letscher‐Bru, Elena De Carolis, Lauro Damonti, Marie Titécat, Pierre–Yves Bochud, Alexandre Alanio, Maurizio Sanguinetti, Claudio Viscoli, Raoul Herbrecht, Yann Guérardel, Daniel Poulain	2019	14
2	The Ligurian HIV Network: How Medical Informatics Standards Can Help Clinical Research Studies in health technology and informatics ·Barbara Giannini, Sara Mora, Bagus Naufal Fitron, Antonio Di Biagio, Giovanni Cenderello, Chiara Dentone, Maurizio Setti, Daniela Fenoglio, Giovanni Cassola, Claudio Viscoli, Mauro Giacomini	2019	0
3	Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications Clinical Microbiology and Infection ·Daniele Roberto Giacobbe, Tommaso Giani, Matteo Bassetti, Anna Marchese, Claudio Viscoli, Gian María Rossolini	2019	56
4	Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? PLoS neglected tropical diseases ·Niccolò Riccardi, Odelia Putri Shabrina, Francesca Peraldo, J. Czech, Lucia Taramasso, Paolo Traverso, Claudio Viscoli, Antonio Di Biagio, Lorenzo E. Derchi, Andrea De Maria	2017	25
5	Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency. PubMed ·Giovanni Cenderello, Antonio Di Biagio, Niccolò Riccardi, Lucia Taramasso, Andrea De Maria, Giovanni Cassola, Claudio Viscoli	2016	1
6	Lower sensitivity of serum (1,3)-β- d -glucan for the diagnosis of candidaemia due to Candida parapsilosis Clinical Microbiology and Infection ·Małgorzata Mikulska, Daniele Roberto Giacobbe, Elisa Furfaro, Alessio Mesini, Anna Marchese, Valerio Del Bono, Claudio Viscoli	2016	33
7	Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population Epidemiology and Infection ·Cristiano Alicino, Daniele Roberto Giacobbe, Paolo Durando, Dumariani Silalahi, Gao Xin-lei, Chiara Paganino, Valerio Del Bono, Claudio Viscoli, Giancarlo Icardi, Andrea Orsi	2016	18
8	Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study Journal of Antimicrobial Chemotherapy ·Mario Tumbarello, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, Maddalena Giannella, Daniele Roberto Giacobbe, Matteo Bassetti, Angela Raffaella Losito, Michele Bartoletti, Valerio Del Bono, Silvia Corcione, G. Maiuro, Sara Tedeschi, Luigi Celani, Chiara Simona Cardellino, Teresa Spanu, Anna Marchese, Simone Ambretti, Roberto Cauda, Claudio Viscoli, Pierluigi Viale, (unknown) Hit paper breakdown →	2015	395
9	Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project) AIDS Research and Human Retroviruses ·Bianca Bruzzone, Francesco Saladini, Laura Sticchi, Bayu Prasetya Putra, Alessio Bonadio, Patrizia Caligiuri, A Davoudifar, Maurizio Zazzi, Giancarlo Icardi, Claudio Viscoli, Maura Macciò	2015	6
10	Disseminated Histoplasmosis with Mucocutaneous Immune Reconstitution Inflammatory Syndrome in an HIV-Infected Patient AIDS Research and Human Retroviruses ·Emanuele Delfino, Antonio Di Biagio, Jonathan L. Tilly, Claudio Viscoli, Roberta Prinapori	2015	5
11	Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study Clinical Microbiology and Infection ·Maddalena Giannella, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, Valerio Del Bono, Matteo Bassetti, Russell E. Lewis, Angela Raffaella Losito, Silvia Corcione, Carolina Saffioti, Michele Bartoletti, G. Maiuro, Chiara Simona Cardellino, Sara Tedeschi, Roberto Cauda, Claudio Viscoli, Pierluigi Viale, Mario Tumbarello	2014	191
12	European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia Haematologica ·Diana Averbuch, Christina Orasch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Claudio Viscoli, Inge C. Gyssens, Winfried V. Kern, G. A. Klyasova, Oscar Marchetti, Dan Engelhard, Murat Akova, (unknown) Hit paper breakdown →	2013	408
13	Voriconazole in clinical practice Journal of Chemotherapy ·Małgorzata Mikulska, Andrea Novelli, Franco Aversa, Simone Cesaro, Francesco Giuseppe De Rosa, Corrado Girmenia, Alessandra Micozzi, Maurizio Sanguinetti, Claudio Viscoli	2012	46
14	Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy Clinical Microbiology and Infection ·Matteo Bassetti, Andrea Parisini, A Davoudifar, Franco M. Bobbio Pallavicini, Giovanni Cassola, Stefania Artioli, Marco Anselmo, Onwuchekwa David, Giovanni Rezza, Claudio Viscoli	2010	26
15	Fungal Infections in Children With Cancer The Pediatric Infectious Disease Journal ·Elio Castagnola, Simone Cesaro, M Giacchino, Susanna Livadiotti, Fábio C. Tucci, Giulio Andrea Zanazzo, Wei-Zhen Kong, Ilaria Caviglia, Stefano Parodi, Roberto Rondelli, Bertha Holliday, Rosamaria Mura, Nicola Santoro, Giovanna Russo, Raffaella De Santis, Salvatore Buffardi, Claudio Viscoli, Riccardo Haupt, Mario Rossi	2006	111
16	Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary British Journal of Haematology ·Elio Castagnola, Angelo Claudio Molinari, Yixuan Bu, Claudio Viscoli	2003	29
17	Clinical and Laboratory Features Predicting a Favorable Outcome and Allowing Early Discharge in Cancer Patients with Low-Risk Febrile Neutropenia: A Literature Review Journal of Hematotherapy & Stem Cell Research ·Elio Castagnola, Dimitri Paola, R. Giacchino, Claudio Viscoli	2000	15
18	[Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B]. PubMed ·Claudio Viscoli, Elio Castagnola	1999	2
19	Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: Case reports with literature review Journal of Infection ·Elio Castagnola, Massimo Conte, E. Laurent, Alberto Garaventa, Claudio Viscoli, UK Samanddar, Walter M. Giffard, Loredana Tasso, Marilina Nantron, Claudia Milanaccio, R. Giacchino	1997	56
20	Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer British Journal of Cancer ·Andrea Ardizzoni, Susanne Kammerer, Marco Danova, Claudio Viscoli, G Mariani, Jim Tour, M. Venturini, Yonghao Wang, DANIEL KETT, R. Rosso	1996	7

About Claudio Viscoli

Claudio Viscoli is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Infectious Diseases, Clinical Biochemistry and Epidemiology, having authored 301 papers that have together received 14.6k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (89 papers), Neutropenia and Cancer Infections (74 papers), Fungal Infections and Studies (72 papers), Antibiotic Resistance in Bacteria (43 papers), Antibiotics Pharmacokinetics and Efficacy (40 papers), Bacterial Identification and Susceptibility Testing (39 papers), HIV/AIDS drug development and treatment (28 papers) and Pneumocystis jirovecii pneumonia detection and treatment (27 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.6k citations), Molecular Medicine (3.5k citations), Clinical Biochemistry (2.9k citations), Infectious Diseases (6.4k citations) and Epidemiology (7.2k citations). Claudio Viscoli has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Matteo Bassetti, Małgorzata Mikulska, Elio Castagnola, Valerio Del Bono, Thierry Calandra, Daniele Roberto Giacobbe, M. P. Glauser, Mario Tumbarello, Andrea Bacigalupo and Elda Righi. Their work appears in journals such as Clinical Infectious Diseases, Clinical Microbiology and Infection, Journal of Chemotherapy, Journal of Antimicrobial Chemotherapy and BMC Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact